Anna Luganini

1.6k total citations
57 papers, 1.3k citations indexed

About

Anna Luganini is a scholar working on Epidemiology, Molecular Biology and Immunology. According to data from OpenAlex, Anna Luganini has authored 57 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 16 papers in Molecular Biology and 12 papers in Immunology. Recurrent topics in Anna Luganini's work include Cytomegalovirus and herpesvirus research (24 papers), Herpesvirus Infections and Treatments (17 papers) and Toxoplasma gondii Research Studies (7 papers). Anna Luganini is often cited by papers focused on Cytomegalovirus and herpesvirus research (24 papers), Herpesvirus Infections and Treatments (17 papers) and Toxoplasma gondii Research Studies (7 papers). Anna Luganini collaborates with scholars based in Italy, United States and France. Anna Luganini's co-authors include Giorgio Gribaudo, Santo Landolfo, Valentina Dell’Oste, Patrizia Caposio, Marisa Gariglio, Marco De Andrea, Maria Elena Terlizzi, Beatrice Mercorelli, Arianna Loregian and Deborah Gatti and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and The Journal of Immunology.

In The Last Decade

Anna Luganini

56 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Luganini Italy	21	573	398	379	168	106	57	1.3k
Yunn‐Hwen Gan Singapore	30	1.0k 1.8×	653 1.6×	340 0.9×	263 1.6×	49 0.5×	71	2.2k
Yuko Yoshikawa Japan	19	580 1.0×	866 2.2×	436 1.2×	175 1.0×	160 1.5×	44	1.8k
Maria Aparecida de Souza Brazil	21	348 0.6×	275 0.7×	264 0.7×	125 0.7×	243 2.3×	60	1.2k
Soheila Ajdary Iran	19	340 0.6×	396 1.0×	248 0.7×	140 0.8×	77 0.7×	83	1.2k
Sérgio Henrique Seabra Brazil	23	607 1.1×	376 0.9×	219 0.6×	326 1.9×	374 3.5×	77	1.5k
R. Robert France	24	404 0.7×	547 1.4×	191 0.5×	695 4.1×	81 0.8×	84	1.6k
Christian Alexander Germany	14	350 0.6×	424 1.1×	1.0k 2.7×	168 1.0×	46 0.4×	31	1.7k
Miguel Vargas Mexico	20	158 0.3×	538 1.4×	222 0.6×	402 2.4×	293 2.8×	65	1.5k
Ivete Conchon‐Costa Brazil	24	418 0.7×	308 0.8×	197 0.5×	172 1.0×	341 3.2×	112	1.6k
Oleg Krut Germany	27	574 1.0×	1.2k 3.0×	376 1.0×	537 3.2×	60 0.6×	43	2.6k

Countries citing papers authored by Anna Luganini

Since Specialization

Citations

This map shows the geographic impact of Anna Luganini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Luganini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Luganini more than expected).

Fields of papers citing papers by Anna Luganini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Luganini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Luganini. The network helps show where Anna Luganini may publish in the future.

Co-authorship network of co-authors of Anna Luganini

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Luganini. A scholar is included among the top collaborators of Anna Luganini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Luganini. Anna Luganini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Ferraris, Sara, Sergio Perero, Giacomo Maculotti, et al.. (2025). A biocompatible SiO2/ZnO coating with enhanced antibiofilm properties for dental applications. Applied Surface Science. 690. 162590–162590.

2.

Mannino, Giuseppe, Ilaria Frasson, Anna Luganini, et al.. (2024). The Novel A-Type Proanthocyanidin-Rich Phytocomplex SP4™ Acts as a Broad-Spectrum Antiviral Agent against Human Respiratory Viruses. International Journal of Molecular Sciences. 25(13). 7370–7370. 4 indexed citations

3.

Mandras, Narcisa, Anna Luganini, Monica Argenziano, et al.. (2023). Design, Characterization, and Biological Activities of Erythromycin-Loaded Nanodroplets to Counteract Infected Chronic Wounds Due to Streptococcus pyogenes. International Journal of Molecular Sciences. 24(3). 1865–1865. 3 indexed citations

4.

Luganini, Anna, Maurizia Mello‐Grand, Stefano Sainas, et al.. (2023). Mechanisms of antiviral activity of the new hDHODH inhibitor MEDS433 against respiratory syncytial virus replication. Antiviral Research. 219. 105734–105734. 6 indexed citations

5.

Alovisi, Mario, Damiano Pasqualini, Narcisa Mandras, et al.. (2022). Confocal Laser Scanner Evaluation of Bactericidal Effect of Chitosan Nanodroplets Loaded with Benzalkonium Chloride. Journal of Clinical Medicine. 11(6). 1650–1650. 8 indexed citations

6.

Luganini, Anna, et al.. (2022). The Novel hDHODH Inhibitor MEDS433 Prevents Influenza Virus Replication by Blocking Pyrimidine Biosynthesis. Viruses. 14(10). 2281–2281. 13 indexed citations

7.

Barbero, Francesca, et al.. (2022). Forests influence yeast populations vectored by insects into vineyards. Frontiers in Microbiology. 13. 1039939–1039939. 8 indexed citations

8.

Banche, Giuliana, Valeria Allizond, Narcisa Mandras, et al.. (2022). Antimicrobial oxygen-loaded nanobubbles as promising tools to promote wound healing in hypoxic human keratinocytes. Toxicology Reports. 9. 154–162. 13 indexed citations

9.

Calistri, Arianna, Anna Luganini, Barbara Mognetti, et al.. (2021). The New Generation hDHODH Inhibitor MEDS433 Hinders the In Vitro Replication of SARS-CoV-2 and Other Human Coronaviruses. Microorganisms. 9(8). 1731–1731. 25 indexed citations

10.

Mercorelli, Beatrice, Marta Celegato, Anna Luganini, et al.. (2021). The antifungal drug isavuconazole inhibits the replication of human cytomegalovirus (HCMV) and acts synergistically with anti-HCMV drugs. Antiviral Research. 189. 105062–105062. 8 indexed citations

11.

Bozzano, Federica, Mariella Della Chiesa, Andrea Pelosi, et al.. (2021). HCMV-controlling NKG2C+ NK cells originate from novel circulating inflammatory precursors. Journal of Allergy and Clinical Immunology. 147(6). 2343–2357. 16 indexed citations

12.

Mandras, Narcisa, Mario Alovisi, Janira Roana, et al.. (2020). Evaluation of the Bactericidal Activity of a Hyaluronic Acid-Vehicled Clarithromycin Antibiotic Mixture by Confocal Laser Scanning Microscopy. Applied Sciences. 10(8). 761–761. 5 indexed citations

13.

Mandras, Narcisa, Mario Alovisi, Janira Roana, et al.. (2020). Evaluation of the Bactericidal Activity of a Hyaluronic Acid-Vehicled Clarithromycin Antibiotic Mixture by Confocal Laser Scanning Microscopy. Applied Sciences. 10(3). 761–761. 1 indexed citations

14.

Chatterjee, Aroni, et al.. (2020). In Vitro Search for Antiviral Activity against Human Cytomegalovirus from Medicinal Mushrooms Pleurotus sp. and Lentinus sp.. Journal of Antivirals & Antiretrovirals. 12(4). 1–7. 7 indexed citations

15.

Bovio, Elena, Laura Garzoli, A. Poli, et al.. (2019). Marine Fungi from the Sponge Grantia compressa: Biodiversity, Chemodiversity, and Biotechnological Potential. Marine Drugs. 17(4). 220–220. 53 indexed citations

16.

Luganini, Anna, Maria Elena Terlizzi, Gianluca Catucci, et al.. (2018). The Cranberry Extract Oximacro® Exerts in vitro Virucidal Activity Against Influenza Virus by Interfering With Hemagglutinin. Frontiers in Microbiology. 9. 1826–1826. 45 indexed citations

17.

Argenziano, Monica, Giuliana Banche, Anna Luganini, et al.. (2017). Vancomycin-loaded nanobubbles: A new platform for controlled antibiotic delivery against methicillin-resistant Staphylococcus aureus infections. International Journal of Pharmaceutics. 523(1). 176–188. 46 indexed citations

18.

Fionda, Cinzia, Valentina Dell’Oste, Anna Luganini, et al.. (2016). Distinct Roles for Human Cytomegalovirus Immediate Early Proteins IE1 and IE2 in the Transcriptional Regulation of MICA and PVR/CD155 Expression. The Journal of Immunology. 197(10). 4066–4078. 23 indexed citations

19.

Terlizzi, Maria Elena, Andrea Occhipinti, Anna Luganini, Massimo E. Maffei, & Giorgio Gribaudo. (2016). Inhibition of herpes simplex type 1 and type 2 infections by Oximacro®, a cranberry extract with a high content of A-type proanthocyanidins (PACs-A). Antiviral Research. 132. 154–164. 34 indexed citations

20.

Prete, Annalisa Del, Anna Luganini, Sara Scutera, et al.. (2014). Interferon-α Production by Plasmacytoid Dendritic Cells Is Dispensable for an Effective Anti-Cytomegalovirus Response in Adaptor Protein-3-Deficient Mice. Journal of Interferon & Cytokine Research. 35(3). 232–238. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact